Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The Spanish gut microbiome reveals links between microorganisms and Mediterranean diet


Despite the increasing evidence of links between human gut and health, the number of gut microbiomes that have been studied to date at a country level are surprisingly low. Mediterranean countries, including some of the most long-lived and healthy countries in the world, have not been considered so far in those studies at a large scale. The main objective of this work is to characterize the gut microbiome of a healthy adult population of a Mediterranean, paradigmatically healthy country: Spain. Stool samples from 530 healthy volunteers were collected, total metagenomic DNA extracted, and the microbial profiles determined through 16S rRNA metataxonomic sequencing. Our results confirm the associations between several microbial markers and different variables, including sex, age, BMI and diet choices, and bring new insights into the relationship between microbiome and diet in the Spanish population. Remarkably, some of the associations found, such as the decrease of Faecalibacterium with age or the link of Flavonifractor with less healthy dietary habits, have been barely noticed in other large-scale cohorts. On the other hand, a range of links between microorganisms, diet, and lifestyle coincide with those reported in other populations, thus increasing the robustness of such associations and confirming the importance of these microbial markers across different countries. Overall, this study describes the Spanish “normal” microbiome, providing a solid baseline for future studies investigating the effects of gut microbiome composition and deviations in the adherence to the Mediterranean diet.


Human gut is one of the most diverse ecosystems on Earth. As a result of millions of years of co-evolution, gut microorganisms perform essential activities for human health and nutrition, from the digestion of vegetal fiber1 to the regulation of complex signalling pathways acting beyond our gut2,3. Since the development of metagenomic sequencing techniques, the human gut microbiome has been a recurrent object of study. In 2007, The Human Microbiome Project (HMP) was launched with two main objectives: (1) understanding the dimension of the microbial communities associated to the human body, regarding variability among individuals; and (2) shedding light on the interplay between gut microbiota and a range of diseases4,5. To date, nearly 6.000 gut microbiome samples (out of more than 31.000 corresponding to different body sites) have been analyzed in the framework of the HMP. These datasets originate from individuals of different sex, age, culture, geographic location, and health status, which implies multiple potential connections between the composition of the gut microbiome and a range of health issues and diseases6,7. In order to shed light on those correlations, the microbiome profiles of different cohorts (usually, healthy vs diseased) are often compared, and differences involving single microorganisms8,9, microbial consortia10, or dynamic behaviors of the community are identified11.

The definition of a “normal” (or “healthy”) microbiome is crucial to understand how this microbiome is altered as a consequence of any factor. However, the systematic analysis of the microbiome of healthy individuals has only been addressed by a few studies, and the very concept of “normal” microbiome is still controversial12,13. Since a range of factors associated to climate, geography, and culture are known to influence the gut microbiome14,15,16, the precise definition of a normal microbiome should be restricted to a given population, of the same region/country and with similar diet and lifestyle habits. Moreover, and in order to assess the associations of microorganisms with specific phenotypic or environmental factors (e.g., age, sex, diet, disease states, etc.), it is necessary to know the natural variability in healthy individuals through the study of large cohorts, since many traits are multifactorial and caused by small effects from many variants13,17. To date, only a few large (over 500 people) cohort-based human faecal microbiome studies have been conducted, including English, Dutch, Belgian, German, Israeli, North American, and South African cohorts13,17,18,19,20,21. These studies have identified microbial markers associated with phenotypic traits13,17,18,19, pathological processes, medicine consumption21, and lifestyle20, among other factors.

With a population of more than 47 million citizens, Spain represents a particular case of study. From a geographical point of view, the Spanish territory includes the peninsular region, the Balearic and Canary Islands, and the cities of Ceuta and Melilla (located on the northwest coast of Africa). Regarding climate, Spain is the most diverse country in Europe, including regions with oceanic, warm Mediterranean, hot Mediterranean, and arid climates in the peninsula, and a tropical climate in the Canary Islands. One of the main traits of the Spanish culture is the Mediterranean diet, characterized by the prevalent uptake of vegetables, fruits, legumes, beans, cereals, fish, and unsaturated fats such as olive oil. The health benefits of this type of diet are well known22,23, and its impact on the gut microbiome has been addressed in recent works24,25. This, along with other cultural and social aspects, is one of the main reasons why Spain is considered the country with the highest lifespan26 and life quality27.

The objective of the present work is to shed light on the "normal" microbiome of the Spanish population, as a particular case of Mediterranean countries, in which gut microbiomes, at a epidemiological level, have surprisingly not been studied so far in a comprehensive way. In order to fill this gap, a representative cohort of individuals was selected according to demographic criteria (age, sex, and geographic location), and their stool microbiome was analyzed through 16S rRNA metataxonomic sequencing following the HMP standard guidelines. Our results depict the diversity and variability of the Spanish microbiome regarding sex, geography, and age range of healthy individuals, and confirm or unveil new microbiome-health correlations among particular microbial markers and a range of diet variables, most of which involve the consumption of food associated to the Mediterranean diet.


Dataset description

A total of 530 individuals (267 females and 263 males) across the Spanish territory (including the Canary and Balearic Islands, Ceuta and Melilla) joined the study (Supplementary Table 1). The sample was designed to be representative of the Spanish population in terms of sex, age and geographical distribution. All the samples were associated to basic metadata of the donor (age range, sex and region), while 528 participants provided extended metadata (weight, height, eating habits, medical conditions, etc.) via online questionnaires (Supplementary Table 2). Microbiome sequencing resulted in 36,441,101 joined reads after quality filtering and chimera removal, yielding a median of 71,402 reads per sample (Q1 = 41,271, Q3 = 93,216). Rarefaction curves indicated that all the samples reached the asymptote (Supplementary Fig. 1).

The Spanish gut microbiome

A total of 25,764 different ASVs were detected in the entire dataset. At the phylum level, the average Spanish gut microbiome was dominated by Firmicutes (~ 53.9%) and Bacteroidota (or Bacteroidetes) (~ 37.2%), followed by Proteobacteria (~ 5%), Verrucomicrobiota (or Verrucomicrobia) (~ 1.8%), and Actinobacteriota (or Actinobacteria) (~ 0.9%). The average Firmicutes/ Bacteroidota (F/B) ratio was 1.78 (CI 1.99–1.57).

The dominant genera were Bacteroides (~ 18.4%) and Faecalibacterium (~ 12.5%), followed by Prevotella (6.7%), Alistipes (~ 3.4%), and Oscillospiraceae UCG-002 (~ 2.3%). An average of 100 ± 18 different genera (out of 447 globally detected), and 8 ± 2 different phyla (out of 21) were detected in each individual sample. The average richness and Shannon indices at the ASV level were 283 ± 77 and 4.3 ± 0.4, respectively.

The Balearic Islands presented the lowest average values for alpha diversity metrics (richness: 224.5; Shannon: 4.1), while Navarra and La Rioja regions (Northern Spain) showed the highest richness (332.3; Fig. 1A) and Shannon values (4.6; Fig. 1B), respectively. It is worth highlighting that the number of participants recruited for each Spanish region was proportional to the population of this region with respect to the total population of Spain (Supplementary Table 1). As this could result in a bias towards higher or lower microbial diversity in the most or least represented regions in the cohort, this effect was further investigated, and no significant association was found between the number of individuals and the average alpha diversity metrics of each region (p-value > 0.05; Spearman’s rank correlation) (Supplementary Fig. 2). To study the region-specific patterns of microbial diversity, the cohort was divided in three main categories: Mediterranean regions (Catalonia, Valencian Community, Region of Murcia and Andalusia), islands (Canary and Balearic Islands), and rest of the Spanish mainland. No significant differences were found across these regions in terms of alpha diversity. Results of the pairwise comparisons of the individual regions (i.e., Spanish Autonomous Regions) were not significant either (FDR-adjusted p-value > 0.05; Wilcoxon rank-sum test; Supplementary Table 3). Interestingly, gut microbial profiles from people living in islands differed from those profiles obtained from participants who resided in mainland Spain. In particular, the phylum Patescibacteria and twelve other genera were significantly over- or under-represented when comparing island and mainland profiles (p-value < 0.05; DESeq2 test) (Supplementary Table 4). In contrast, no significant differences were found between Mediterranean regions and the rest of the Spanish mainland.

Figure 1

Diversity indices (A: Richness or Observed ASVs; B: Shannon) across the Spanish territory and (C) distribution of the main taxa (phylum and genus level) in the gut microbiome of male and female individuals. Maps were created with rdgal (v. 1.5-16; and ggplot2 (v. 3.3.1;

Gut microbiomes of males and females were markedly similar (Fig. 1C). Nevertheless, the abundance of the phylum Proteobacteria and the genus Faecalibacterium were significantly higher in males than in females (p-value < 0.05; DESeq2 test) (Fig. 2A). There were eight additional genera whose abundances differed between these two groups, including Oscillibacter and Anaerostipes (Supplementary Table 5). No significant differences between genders were found in terms of alpha diversity (p-value > 0.05; Wilcoxon rank-sum test).

Figure 2

Associations of particular markers with sex and age. (A) Relative abundance of Faecalibacterium and Proteobacteria in male and female individuals. (B) Genera showing a significant Spearman’s rank correlation (FDR-adjusted p-value < 0.05) with age. Rho = Spearman's rank correlation coefficient. (C) Relative abundance of Bifidobacterium in different age groups. (D) Shannon index vs. age considering the whole cohort (left) (linear model “lm” used as smoothing method) or separating by sex (right) (local polynomial regression fitting model “loess” used as smoothing method). Rho and p-values resulting from Spearman’s rank correlation are shown. Black = both females and males; Red = females; Blue = males.

A relatively high number of microbial markers were associated with age. Specifically, age significantly correlated with one phylum (Cyanobacteria) and 29 different genera (Fig. 2B and Supplementary Table 6) (p-value < 0.05; Spearman’s rank correlation). Eight of these genera (Faecalibacterium, Clostridia UCG-014, Phascolarctobacterium, Eubacterium eligens group, Dialister, Eubacterium siraeum group, an unassigned Muribaculaceae, and an unassigned Lachnospiraceae) were among the top 30 taxa with the highest average relative abundance (rel. abund. > 0.7%). Remarkably, Bifidobacterium relative abundance also decreased with age (Fig. 2C). Both alpha diversity metrics studied (richness & Shannon; ASV-level) were also age-dependent, and they increased linearly with age (p-value < 0.05; Spearman’s correlation) (Fig. 2D and Supplementary Fig. 3). When splitting the dataset by sex, a positive correlation between age and alpha diversity indices were found for males, but not for females (Fig. 2D and Supplementary Fig. 3). Although both richness and Shannon metrics were noticeably higher for young adult females, no significant results were obtained when comparing males and females aged below 40 years (p-value > 0.05; Wilcoxon rank-sum test).

Gut microbiome associations with diet-related variables

The information on diet habits collected from 528 participants was used to establish correlations between microbiome data (at the phylum and genus level) and the monthly consumption of 43 different foods (e.g., bread, yogurt, milk, etc.) and food groups (e.g., nuts, sugar-sweetened beverages, etc.). Body mass index (BMI) was also included as a variable. In order to reduce the complexity and dimensionality of genus-level microbiome data, only genera with a relative abundance > 0.01% were tested (n = 171). No filtering was applied to the phylum-level data (n = 21). Spearman’s rank correlation was used to identify 63 genera associated with 19 variables (Fig. 3A), and 8 phyla associated with 11 variables (Fig. 3B) (p-value < 0.05; Spearman’s rank correlation). Verrucomicrobiota and both Eubacterium eligens group and Flavonifractor resulted in the highest number of significant associations at the phylum and genus level (five and seven associations, respectively). On the other hand, monthly consumption of nuts was associated with the highest number of microbial markers (23 phyla or genera) (Supplementary Table 7).

Figure 3

Associations of microbial taxa (A: Genera; B: Phyla) with the consumption of particular foods or food groups. Only significant associations are shown (FDR-adjusted p-value < 0.05). Only taxa or foods/food groups showing at least one significant association are shown. Positive Spearman's rank correlation coefficients (positive associations) are colored in red, while negative values (negative associations) are colored in blue. A full description of the foods included in each food group can be found in the Supplementary Note.

Although the different diet variables analyzed displayed correlations with different microbial taxa, the consumption of garnish vegetables, salad, green beans/chard/spinach, and nuts, resulted in similar correlations in terms of microbial patterns. Interestingly, these associations tended to be the opposite of those established for the consumption of sugar-sweetened beverages (Fig. 3A).

Flavonifractor was a paradigmatic example: it was positively associated with sugar-sweetened drinks, but negatively associated with the consumption of nuts, fruits, and miscellaneous vegetables. Similarly, the abundance of Ruminococcus torques group was positively associated with indicators of meat consumption, and negatively associated with nuts and green beans/chard/spinach.

Conversely, Eubacterium eligens group was positively associated with nuts, salad and green beans/chard/spinach consumption, and negatively associated with minced beef among others. Remarkably, taxa associated with BMI showed no correlation with other diet variables, except for Marvinbryantia and Christensenellaceae R-7 group, which were negatively associated with BMI and positively associated with nuts consumption. At the phylum level, a correlation was established between BMI and Proteobacteria. Moreover, five diet variables (corresponding to food or food groups with a high sugar content) were associated with a reduction of Verrucomicrobiota (Fig. 3B).

Finally, the relationship between age, sex and dietary habits was studied. The monthly consumption of sixteen different foods or food groups was associated to age (Supplementary Table 8), while seventeen diet variables were sex-dependent (Supplementary Table 9). Overall, the consumption of healthier foods (e.g., salad or citrus fruit) increased with age, while less healthy dietary habits (e.g., consumption of sugar-sweetened beverages or chips) presented a negative correlation with this variable. Regarding sex, females tended to adhere to healthier dietary patterns: they reported a lower consumption of beer, spirit drinks or sugar-sweetened beverages, and a higher consumption of fruits and vegetables.


We report here the analysis of the Spanish Microbiome, based on a total of 530 faecal samples, as a proxy of the "normal" gut microbiome of the Spanish population. Although similar studies have been carried out for other European countries, such as UK, Germany, Belgium or the Netherlands13,18,19,21, to the best of our knowledge, this is the first large-scale, country-wide gut microbiome analysis in a Mediterranean country.

The two most dominant bacterial phyla in the Spanish gut microbiome were Firmicutes and Bacteroidota, followed by Proteobacteria, Verrucomicrobiota and Actinobacteriota. This taxonomic composition is typically reported in healthy individuals12,19,20,28,29,30,31. The Firmicutes/Bacteroidota (F/B) ratio has been widely used to detect dysbiosis associated with pathologies, although the usefulness of this marker is currently under debate32. Increased or decreased F/B ratio is related to dysbiosis, whereby the former is usually observed with obesity, and the later with inflammatory bowel disease20,31. In our study, the average F/B ratio was in line with the ratios observed in other healthy cohorts from distant geographical regions such as the US, UK, Chile, Colombia, and Argentina. However, cohorts from India and Pakistan showed slightly lower F/B values (< 1.0)32. In some cases, the F/B ratio can vary by more than an order of magnitude among people30, but such large deviations usually are outliers.

At the genus level, the dominant taxa of the Spanish faecal microbiome were Bacteroides and Faecalibacterium, followed by Prevotella, Alistipes, and Oscillospiraceae, all of them belonging to the dominant phyla Firmicutes and Bacteroidota. Bacteroides and Faecalibacterium are typically the dominant genera regardless of the geography of the cohorts13,19,30,31. When comparing the relative abundances of Bacteroides with previous studies, it should be considered that some members of the former genus Bacteroides have recently been reclassified into five genera, i.e., Alistipes, Prevotella, Paraprevotella, Parabacteroides, and Odoribacter, and hence the relative abundances can vary33,34.

In our study, we found minor differences between the microbiome of Spanish males and females. Interestingly, Spanish males showed a higher abundance of Faecalibacterium than females. Faecalibacterium is a producer of short-chain fatty acids35 and one of the most fibrolytic bacteria of the gut36. This genus was also found at higher relative abundances in males in other cohorts37 and was linked to the development of some metabolic syndromes in men38. The differences of some key taxa such as Faecalibacterium may contribute to the sexual dimorphism of autoimmune36,39,40 and neuroimmune diseases41.

The abundance of Faecalibacterium, Bacteroides, Bifidobacterium and Akkermansia has been proved to depend on age42. In our study, a reduction in the abundance of Faecalibacterium and Bifidobacterium with age was detected, but significant associations between age and Akkermansia or Bacteroides were not found. Faecalibacterium is often described to be negatively associated with age43,44,45, while both negative and positive associations have been found for Bifidobacterium and aging44,46,47,48. The abundance of the Lachnospiraceae family has also been previously reported to decrease in the elderly47. Nonetheless, all the eight taxa belonging to this family (according to SILVA v.138 taxonomy) which displayed a significant association with age in this study (Lachnospiraceae UCG-003, Lachnospiraceae UCG-008, Lachnospiraceae ND3007 group, an unassigned Lachnospiraceae, Butyrivibrio, Eubacterium xylanophilum group, Eubacterium eligens group and Howardella) showed, indeed, a positive correlation. Streptococcus was also negatively associated to age in our dataset, which was in line with previous findings45. Apart from the highlighted taxa, the abundance of eighteen additional genera was found to be age-dependent, suggesting that age is a key factor for understanding the gut microbiome of the Spanish population. It has to be noted that taxonomic changes associated with aging may not be directly attributable to age itself, but to different dietary and lifestyle habits across the different age groups44,49,50.

Alpha diversity has demonstrated to play an essential role for understanding the human gut microbiome, since loss of microbial diversity have been linked to intestinal dysbiosis in several human diseases51,52. With this in mind, investigating the distribution of alpha diversity metrics in the “normal” (or “healthy”) population is key. From all the variables included in the study (sex, BMI, dietary habits, etc.), only age was significantly associated with alpha diversity (positive correlation). This association has previously been found in other European, American and Asian cohorts53,54. In fact, according to Badal et al. (2020)44 review, no studies have ever confirmed a negative association of alpha diversity with age. Interestingly, our results replicated two specific findings described by de la Cuesta-Zuluaga et al. (2019)53: (1) the increase in alpha diversity is more noticeable in young adults, with a change in the trend at around age 40; and (2) young adult females present a higher—yet not significant in this case—alpha diversity (and especially a higher richness) when compared to males of the same age range, suggesting that gut microbiome development throughout the early stages of adulthood may be sex-dependent, although more research is still needed.

Diet has also been proved as a crucial factor for understanding the human gut microbiota configuration and its modulation throughout life55,56,57. It is also worth highlighting that Spain is often considered as a paradigmatic example of adherence to the Mediterranean diet, which has been linked to multiple beneficial effects58,59. For that reason, we investigated how the consumption of different foods or food groups influenced the composition of the faecal microbiome.

Some of our findings confirm those of other cohorts and studies, underlining the robustness of the associations across different experimental designs, methodologies and environmental variables. For example, we found a positive correlation between Bifidobacterium and dairy intake, as previously reported60. Indeed, this association is commonly used as an example of the influence of host genetics in the gut microbiota, since it has been proved that the abundance of Bifidobacterium depends on lactase persistence19,61. Beyond genetics, a recent study by Asnicar et al. (2021)45 has shown a significant positive correlation between lactose and the abundance of three different Bifidobacterium species (B. catenulatum, B. longum and B. animalis). An association between yogurt, galactose and lactose with higher abundances of Streptococcus thermophilus was also identified, which matched our observation of a positive correlation between the genus Streptococcus and yogurt consumption in the Spanish cohort.

Remarkably, nuts were the food group with the higher number of associations with the microbial markers reported in Asnicar et al. (2021)45, as also noted in our study. This could be expected, since nuts are rich in fiber and polyphenols62, both of which have been widely demonstrated to modulate the function and composition of the gut microbiota55,56,63. Despite discrepancies in the methodologies used in both studies for studying the microbiome (Asnicar et al. (2021)45 used shotgun metagenomic sequencing and reached the species level, while we used a metataxonomic approach and reached the genus level), some of the identified associations were similar. Specifically, we found nuts consumption to be associated with the Eubacterium eligens group, Bifidobacterium, and Flavonifractor, while Asnicar et al. (2021)45 described correlations -in the same direction- for Eubacterium eligens, F. plautii, B. bifidum and B. catenulatum, but the opposite correlation was found for B. animalis. We identified a negative correlation for the abundance of Lactobacillus in the gut and nut consumption. Similarly, Creedon et al. (2020)62 described that pistachio consumption decreased the number of lactic acid bacteria. Paradoxically, although nuts have proved to have potential prebiotic effects64,65, negative correlations between nut consumption and Lactobacillus and Bifidobacterium, which are commonly used as probiotics, have been established. So, further research is still needed in order to depict the underlying mechanisms explaining this phenomenon.

We also revealed microbial associations in opposite directions between food groups that usually reflect antagonistic dietary habits (i.e., nuts, vegetables and fruits vs. meat and sugary drinks), which was in line with the behaviour described by Asnicar et al. (2021)45 For instance, Flavonifractor showed a negative correlation with healthy plant-based food groups (garnish vegetables, salad, green beans/chard/spinach, other fruits and nuts), and a positive correlation with less healthy food groups (sugar sweetened beverages and the group formed by pizza, croquette and others). Surprisingly, these results overlapped almost completely with the associations described for F. plautii by Asnicar et al. (2021)45, which indeed reported negative correlations between this species and multiple health indicators, including BMI and visceral fat. The genus Flavonifractor and the species F. plautii have been previosuly linked to different diseases and disorders, such as major depression disorder66, bipolar disorder67 or colorectal cancer68. Moreover, it is worth highlighting that F. plautii was negatively associated with adherence to MD69, while its abundance was reduced after switching to this diet70. F. plautii is a flavonoid-degrading bacterium, which has been suggested to potentially reduce the bioavailability of beneficial flavonoid67,68, although the specific mechanisms explaining the role of Flavonifractor in health and disease are not yet clear and require further investigation.

Another interesting case is that of Eubacterium eligens group and Ruminococcus torques group. The former was positively associated with healthy foods and negatively associated with minced beef (including hamburgers and sausages), spirits and the pizza/croquette/other group, which was similar to what was reported by other studies18,45. The latter was rather positively and negatively associated to animal-based and plant-based foods, respectively. These bacteria have been previously linked to vegetarian (Eubacterium eligens) and non-vegetarian (Ruminococcus torques) subjects71. Moreover, Eubacterium eligens was linked to a higher adherence to the MD69 and to a beneficial health signature45, while Ruminococcus torques has been negatively associated with MD69,70. Altogether, and considering that the Spanish population mainly follow the MD, Flavonifractor (or F. plautii), Ruminococcus torques group, and Eubacterium eligens group could be proposed as gut microbial markers of adherence to this diet.

Other remarkable associations found in the studied Spanish cohort were:

  1. (1)

    a negative correlation between Akkermansia, a genus which has been inversely linked to several disease states72 and higher consumption of sugary drinks and spirits. This contrasted with previous studies73,74, although a negative association between Akkermansia and other sugar-rich foods has been previously reported75.

  2. (2)

    An inverse correlation between wine consumption and both Bifidobacterium and Acidaminicoccus. Interestingly, a decrease in the abundance of Acidaminococcus sp. D21 has been linked to alcohol dependence syndrome and liver cirrhosis76, while a negative correlation between B. bifidum and alcohol intake has been previously described45.

  3. (3)

    A positive correlation between legumes consumption, one of the key signatures of MD, and Coprococcus. This genus proved to increase with higher quality of life indicators and to be depleted in depression77, but its interrelationship with dietary habits is yet unclear.

  4. (4)

    Several correlations between BMI and different genera, including a positive association with the abundance of Roseburia. A positive correlation between R. inulinivorans and BMI was also described by Asnicar et al. (2021)45, although other members of the Roseburia genus (i.e., R. hominis or Roseburia bacterium CAG:182) have been linked to healthy plant-based foods, adherence to MD and other indicators of good health45,69,70. This suggests a species-dependant behaviour of the associations between Roseburia and health parameters, including BMI.

Overall, the present work constitutes the first complete analysis of the gut microbiome of a Mediterranean country. Our findings clearly confirm the association between some of the foods that characterize the Mediterranean diet (vegetables and nuts, basically) with the abundance of bacterial taxa which, in turn, are associated with health benefits. Moreover, dietary habits have demonstrated to be sex- and age-dependent. In particular, females tended to adhere to healthier dietary patterns, while young individuals reported an increased consumption of less healthy foods or food groups. This suggests that adherence to MD in Spain is decreasing among young people, which could have a negative impact on the health condition and gut microbiome composition of the Spanish population. Despite the difficulties encountered when comparing our investigation with other studies because of methodological bias, our results demonstrate or point out the robustness of the associations between healthy lifestyle traits and particular microbial markers, some of which have not been deeply studied in previous nation-wide microbiome studies. Taken together, our results strongly suggest a double effect of the Mediterranean diet on the health of the Spaniards: direct ones (i.e. “inherent” nutritional values such as content in vitamins, fiber, healthy fats, etc.) and indirect ones through a not-yet fully understood, but yet strong association between specific foods, microbial markers and health.

Materials and methods

Study design, participant recruitment, and sample collection

This study targeted healthy citizens with an age ranging from 18 to 70 years, who did not meet any of the exclusion criteria summarized in the Supplementary Note. Briefly, the main exclusion criteria were related to a range of infections, diseases/syndromes, as well as to the intake of antibiotics in the last 6 months. A sample group of 530 individuals was designed in accordance with official demographic data ( in order to have a representative picture of the Spanish population in terms of age, sex, and geography (distributed in 17 autonomous regions and 2 autonomous cities). The number of individuals corresponding to each criterium is shown in Supplementary Table 1.

Volunteer participants were recruited through the ICLANP website (, and selected as follows: first, a standard EQ-5D-5L questionnaire (EuroQol Group, 2009) (Supplementary Note) was used to evaluate the generic health status and to pre-select participants with satisfactory values in five different aspects (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression). Second, an ad hoc questionnaire was used to retrieve participant’s data regarding age, sex, and location, and to evaluate the different exclusion criteria. Finally, the volunteers that obtained a positive evaluation in the previous steps, completed an additional online questionnaire regarding dietary habits (Supplementary Note). Specifically, participants were asked for their weekly and/or monthly consumption (in number of portions) of 43 different foods (e.g., bread, yogurt, milk, etc.) and food groups (e.g., nuts, sugar-sweetened beverages, etc.) (Supplementary Table 2). For those participants that only provided the weekly consumption of certain foods or food groups, the monthly consumption was calculated by multiplying the weekly consumption by four. This data was used for establishing associations between diet-related variables and microbial markers, as described below.

The selected participants signed an informed consent containing all the information on the objectives, general methodology, and data management and protection aspects of the study. Stool sampling was performed by each participant with the Stool Nucleic Acid Collection and Preservation Kit (Norgen Biotek), and the anonymized samples were processed at the facilities of Darwin Bioprospecting Excellence, SL (Valencia, Spain) following the IHMS (International Human Microbiome Standards).

Microbiome sequencing

Samples were received and processed in different batches from May 2019 to September 2020. Briefly, DNA was extracted from stool samples using the Stool Nucleic Acid Isolation Kit (Norgen Biotek) following the manufacturer’s instructions. Then, Qubit × 1 dsDNA HS Assay kit (Qubit 2.0 Fluorometer, Thermo Fisher, Waltham, United States) was used for DNA quantification. The amplicon sequencing protocol targeted the V3 and V4 regions (459 bp) of the 16S rRNA genes with the primers designed on surrounding conserved regions78. Following the Illumina amplicon libraries protocol, DNA amplicon libraries were generated using a limited cycle PCR: initial denaturation at 95 °C for 3 min, followed by 25 cycles of annealing (95 °C 30 s, 55 °C 30 s, 72 °C 30 s) extension at 72 °C 5 min, using a KAPA HiFi HotStart ReadyMix (KK2602). Then, Illumina sequencing adaptors and dual-index barcodes (Nextera XT index kit v2, FC-131–2001) were added to the amplicons. Libraries were normalized and pooled prior to sequencing. The pool containing indexed amplicons was then loaded onto the MiSeq reagent cartridge v3 (MS-102–3003) spiked with 10% PhiX control to improve base calling during sequencing, as recommended by Illumina for amplicon sequencing. Sequencing was conducted using a paired-end, 2X250pb and 2 × 300pb cycle runs on an Illumina MiSeq device.

Bioinformatic and statistical analysis

Raw Illumina sequences were analysed using Qiime2 (v. 2020.8)79. Briefly, the quality of the reads was assessed with the Demux plugin, and primers were subsequently trimmed from the beginning of the reads via DADA2 (q2‐dada2)80. This plugin was also used for denoising and truncating the reads at 245 bp, and for clustering them into amplicon sequence variants (ASVs). The taxonomy of each sequence variant was assigned employing the q2‐feature‐classifier classify‐sklearn naïve Bayes taxonomy classifier81. SILVA (v. 138)82 was used as reference database for taxonomic assignment. SILVA taxonomy nomenclature was used for preparing the figures (i.e., Bacteroidota was used instead of Bacteroidetes).

Microbiome data was analyzed and visualized in R, mainly using phyloseq83 and ggplot2 packages. Rarefaction curves were constructed with the iNEXT and ggiNEXT functions (iNEXT)84. Correlations between quantitative variables (i.e., monthly consumption of foods or food groups, BMI, age, etc.) and the relative abundance of microbiome markers were evaluated using Spearman’s rank correlation test. Categorical variables (i.e., sex, region, etc.) were tested with DESeq2, using its built-in function for normalizing the raw microbiome counts85. All the p-values obtained in both cases were adjusted using p. adjust R function with the Benjamini–Hochberg procedure (FDR), and significance was defined at adjusted p-value < 0.05. Significant correlations were plotted into heatmaps using pheatmap package. Alpha diversity metrics (richness and Shannon) were calculated at the ASV level. For alpha diversity tests, all the samples were rarefied to 15.000 reads to mitigate uneven sequencing depth. Seventeen samples did not reach this threshold and, therefore, were discarded for alpha diversity analysis.

Ethics approval

All the proceedings followed in this study (including data management and protection) were approved by the Ethics Committee of Hospital Clínico San Carlos (Madrid, Spain; project reference 18/557-E). All methods were performed in accordance with the relevant guidelines and regulations. All the participants of the study gave their informed consent.

Data availability

Raw microbiome sequencing data is available for research use only. Access to the data can be requested using the following online form: Supplementary Table 2 includes the metadata of the study. The code and intermediate files used for analyzing the data and creating the figures have been deposited on Github ( The authors confirm that the rest of the results have been included in the article and/or uploaded as supplementary material.


  1. 1.

    Myhrstad, M. C. W., Tunsjø, H., Charnock, C. & Telle-Hansen, V. H. Dietary fiber, gut microbiota, and metabolic regulation-current status in human randomized trials. Nutrients 12, 859 (2020).

    CAS  PubMed Central  Article  Google Scholar 

  2. 2.

    Wang, P. Y. T. et al. Upper intestinal lipids trigger a gut–brain–liver axis to regulate glucose production. Nature 452, 1012–1016 (2008).

    ADS  CAS  PubMed  Article  PubMed Central  Google Scholar 

  3. 3.

    Cryan, J. F. & Dinan, T. G. Mind-altering microorganisms: The impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci. 13, 701–712 (2012).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  4. 4.

    Turnbaugh, P. J. et al. The human microbiome project. Nature 449, 804–810 (2007).

    ADS  CAS  PubMed  PubMed Central  Article  Google Scholar 

  5. 5.

    The Integrative HMP (iHMP) Research Network Consortium. The integrative human microbiome project. Nature 569, 641–648 (2019).

    ADS  Article  CAS  Google Scholar 

  6. 6.

    Hall, A. B., Tolonen, A. C. & Xavier, R. J. Human genetic variation and the gut microbiome in disease. Nat. Publ. Gr. 18, 690–699 (2017).

    CAS  Google Scholar 

  7. 7.

    Armour, C. R., Nayfach, S., Pollard, K. S. & Sharpton, T. J. A metagenomic meta-analysis reveals functional signatures of health and disease in the human gut microbiome. mSystems 4, e00332-18 (2019).

    PubMed  PubMed Central  Article  Google Scholar 

  8. 8.

    Pedersen, H. K. et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature 535, 376–381 (2016).

    ADS  CAS  PubMed  Article  PubMed Central  Google Scholar 

  9. 9.

    Wang, J. & Jia, H. Metagenome-wide association studies: Fine-mining the microbiome. Nat. Rev. Microbiol. 14, 508–522 (2016).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  10. 10.

    Gilbert, J. A. et al. Microbiome-wide association studies link dynamic microbial consortia to disease. Nature 535, 94–103 (2016).

    ADS  CAS  PubMed  Article  PubMed Central  Google Scholar 

  11. 11.

    Martí, J. M. et al. Health and disease imprinted in the time variability of the human microbiome. mSystems 2, e00144-16 (2017).

    PubMed  PubMed Central  Article  Google Scholar 

  12. 12.

    Bäckhed, F. et al. Defining a healthy human gut microbiome: Current concepts, future directions, and clinical applications. Cell Host Microb. 12, 611–622 (2012).

    Article  CAS  Google Scholar 

  13. 13.

    Falony, G. et al. Population-level analysis of gut microbiome variation. Science 352, 560–564 (2016).

    ADS  CAS  PubMed  Article  PubMed Central  Google Scholar 

  14. 14.

    De Filippo, C. et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. U. S. A. 107, 14691–14696 (2010).

    ADS  PubMed  PubMed Central  Article  Google Scholar 

  15. 15.

    Martínez, I. et al. The gut microbiota of rural papua new guineans: Composition, diversity patterns, and ecological processes. Cell Rep. 11, 527–538 (2015).

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  16. 16.

    Yatsunenko, T. et al. Human gut microbiome viewed across age and geography. Nature 486, 222–227 (2012).

    ADS  CAS  PubMed  PubMed Central  Article  Google Scholar 

  17. 17.

    Rothschild, D. et al. An atlas of robust microbiome associations with phenotypic traits based on large-scale cohorts from two continents. bioRxiv (2020).

    Article  Google Scholar 

  18. 18.

    Zhernakova, A. et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352, 565–569 (2016).

    ADS  CAS  PubMed  PubMed Central  Article  Google Scholar 

  19. 19.

    Rühlemann, M. C. et al. Genome-wide association study in 8,956 German individuals identifies influence of ABO histo-blood groups on gut microbiome. Nat. Genet. 53, 147–155 (2021).

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  20. 20.

    Oduaran, O. H. et al. Gut microbiome profiling of a rural and urban South African cohort reveals biomarkers of a population in lifestyle transition. bioRxiv (2020).

    Article  Google Scholar 

  21. 21.

    Jackson, M. A. et al. Gut microbiota associations with common diseases and prescription medications in a population-based cohort. Nat. Commun. 9, 1–8 (2018).

    ADS  Article  CAS  Google Scholar 

  22. 22.

    Trichopoulou, A. et al. Definitions and potential health benefits of the Mediterranean diet: Views from experts around the world. BMC Med. 12, 112 (2014).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  23. 23.

    Tuttolomondo, A. et al. Metabolic and vascular effect of the Mediterranean diet. Int. J. Mol. Sci. 20, 4716 (2019).

    CAS  PubMed Central  Article  Google Scholar 

  24. 24.

    Nagpal, R. et al. Gut microbiome composition in non-human primates consuming a western or Mediterranean diet. Front. Nutr. 5, 28 (2018).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  25. 25.

    Nagpal, R., Shively, C. A., Register, T. C., Craft, S. & Yadav, H. Gut microbiome-Mediterranean diet interactions in improving host health. F1000Research 8, 699 (2019).

    PubMed  PubMed Central  Article  Google Scholar 

  26. 26.

    European Observatory on Health Systems and Policies. State of Health in the EU—Spain—Country Health Profile 2019. European Commission. (2019).

  27. 27.

    HSBC. HSBC Expat Explorer Survey. (2020).

  28. 28.

    Huttenhower, C. et al. Structure, function and diversity of the healthy human microbiome. Nature 486, 207–214 (2012).

    ADS  CAS  Article  Google Scholar 

  29. 29.

    Faith, J. J. et al. The long-term stability of the human gut microbiota. Science (80-.) 341, 1237439 (2013).

    Article  CAS  Google Scholar 

  30. 30.

    Lloyd-Price, J., Abu-Ali, G. & Huttenhower, C. The healthy human microbiome. Genome Med. 8, 1–11 (2016).

    Article  Google Scholar 

  31. 31.

    Stojanov, S., Berlec, A. & Štrukelj, B. The influence of probiotics on the firmicutes/bacteroidetes ratio in the treatment of obesity and inflammatory bowel disease. Microorganisms 8, 1–16 (2020).

    Article  CAS  Google Scholar 

  32. 32.

    Magne, F. et al. The firmicutes/bacteroidetes ratio: A relevant marker of gut dysbiosis in obese patients?. Nutrients 12, 1474 (2020).

    CAS  PubMed Central  Article  PubMed  Google Scholar 

  33. 33.

    Rajilić-Stojanović, M. & de Vos, W. M. The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol. Rev. 38, 996–1047 (2014).

    PubMed  Article  CAS  Google Scholar 

  34. 34.

    Parte, A. C., Carbasse, J. S., Meier-Kolthoff, J. P., Reimer, L. C. & Göker, M. List of prokaryotic names with standing in nomenclature (LPSN) moves to the DSMZ. Int. J. Syst. Evol. Microbiol. 70, 5607–5612 (2020).

    PubMed  PubMed Central  Article  Google Scholar 

  35. 35.

    Candela, M. et al. Modulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet. Br. J. Nutr. 116, 80–93 (2016).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  36. 36.

    Gill, P. A., van Zelm, M. C., Muir, J. G. & Gibson, P. R. Review article: Short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders. Aliment. Pharmacol. Ther. 48, 15–34 (2018).

    CAS  PubMed  Article  Google Scholar 

  37. 37.

    Elderman, M., de Vos, P. & Faas, M. Role of microbiota in sexually dimorphic immunity. Front. Immunol. 9, 1–6 (2018).

    Article  CAS  Google Scholar 

  38. 38.

    Santos-Marcos, J. A. et al. Sex differences in the gut microbiota as potential determinants of gender predisposition to disease. Mol. Nutr. Food Res. 63, 1–11 (2019).

    Article  CAS  Google Scholar 

  39. 39.

    Markle, J. G. M. et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science (80-.) 339, 1084–1088 (2013).

    ADS  CAS  Article  Google Scholar 

  40. 40.

    Yurkovetskiy, L. et al. Gender bias in autoimmunity is influenced by microbiota. Immunity 39, 400–412 (2013).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  41. 41.

    Wallis, A., Butt, H., Ball, M., Lewis, D. P. & Bruck, D. Support for the microgenderome: Associations in a human clinical population. Sci. Rep. 6, 46–52 (2016).

    Article  CAS  Google Scholar 

  42. 42.

    Salazar, N. et al. Age-associated changes in gut microbiota and dietary components related with the immune system in adulthood and old age: A cross-sectional study. Nutrients 11, 1–11 (2019).

    Article  CAS  Google Scholar 

  43. 43.

    De Filippis, F., Pasolli, E. & Ercolini, D. Newly explored Faecalibacterium diversity is connected to age, lifestyle, geography, and disease. Curr. Biol. 30, 4932-4943.e4 (2020).

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  44. 44.

    Badal, V. D. et al. The gut microbiome, aging, and longevity: A systematic review. Nutrients 12, 1–25 (2020).

    Article  Google Scholar 

  45. 45.

    Asnicar, F. et al. Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals. Nat. Med. 27, 321–332 (2021).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  46. 46.

    Rampelli, S. et al. Functional metagenomic profiling of intestinal microbiome in extreme ageing. Aging (Albany, N. Y.) 5, 902–912 (2013).

    CAS  Google Scholar 

  47. 47.

    Biagi, E. et al. Gut microbiota and extreme longevity. Curr. Biol. 26, 1480–1485 (2016).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  48. 48.

    Drago, L., Toscano, M., Rodighiero, V., De Vecchi, E. & Mogna, G. Cultivable and pyrosequenced fecal microflora in centenarians and young subjects. J. Clin. Gastroenterol. 46, 81–84 (2012).

    Article  Google Scholar 

  49. 49.

    Claesson, M. J. et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 488, 178–184 (2012).

    ADS  CAS  PubMed  PubMed Central  Article  Google Scholar 

  50. 50.

    Jeffery, I. B. & O’Toole, P. W. Diet-microbiota interactions and their implications for healthy living. Nutrients 5, 234–252 (2013).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  51. 51.

    Wilkins, L. J., Monga, M. & Miller, A. W. Defining dysbiosis for a cluster of chronic diseases. Sci. Rep. 9, 1–10 (2019).

    ADS  Google Scholar 

  52. 52.

    Mosca, A., Leclerc, M. & Hugot, J. P. Gut microbiota diversity and human diseases: Should we reintroduce key predators in our ecosystem?. Front. Microbiol. 7, 1–12 (2016).

    Article  Google Scholar 

  53. 53.

    de la Cuesta-Zuluaga, J. et al. Age and sex-dependent patterns of gut microbial diversity in human adults. mSystems 4, 1–12 (2019).

    Google Scholar 

  54. 54.

    Odamaki, T. et al. Age-related changes in gut microbiota composition from newborn to centenarian: A cross-sectional study. BMC Microbiol. 16, 1–12 (2016).

    Article  CAS  Google Scholar 

  55. 55.

    Zmora, N., Suez, J. & Elinav, E. You are what you eat: Diet, health and the gut microbiota. Nat. Rev. Gastroenterol. Hepatol. 16, 35–56 (2019).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  56. 56.

    Kolodziejczyk, A. A., Zheng, D. & Elinav, E. Diet–microbiota interactions and personalized nutrition. Nat. Rev. Microbiol. 17, 742–753 (2019).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  57. 57.

    Leeming, E. R., Johnson, A. J., Spector, T. D. & Roy, C. I. L. Effect of diet on the gut microbiota: Rethinking intervention duration. Nutrients 11, 1–28 (2019).

    Article  Google Scholar 

  58. 58.

    Martínez-González, M. A., Gea, A. & Ruiz-Canela, M. The Mediterranean diet and cardiovascular health: A critical review. Circ. Res. 124, 779–798 (2019).

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  59. 59.

    Eleftheriou, D., Benetou, V., Trichopoulou, A., La Vecchia, C. & Bamia, C. Mediterranean diet and its components in relation to all-cause mortality: Meta-analysis. Br. J. Nutr. 120, 1081–1097 (2018).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  60. 60.

    Kato, K. et al. Association between functional lactase variants and a high abundance of Bifidobacterium in the gut of healthy Japanese people. PLoS ONE 13, 1–10 (2018).

    Google Scholar 

  61. 61.

    Goodrich, J. K., Davenport, E. R., Waters, J. L., Clark, A. G. & Ley, R. E. Cross-species comparisons of host genetic associations with the microbiome. Science (80-.) 352, 532–535 (2016).

    ADS  CAS  Article  Google Scholar 

  62. 62.

    Creedon, A. C., Hung, E. S., Berry, S. E. & Whelan, K. Nuts and their effect on gut microbiota, gut function and symptoms in adults: A systematic review and meta-analysis of randomised controlled trials. Nutrients 12, 1–21 (2020).

    Article  CAS  Google Scholar 

  63. 63.

    Kumar, A. S. et al. Beneficial effects of dietary polyphenols on gut microbiota and strategies to improve delivery efficiency. Nutrients 11, 2216 (2019).

    PubMed Central  Article  CAS  Google Scholar 

  64. 64.

    Sugizaki, C. S. A. & Naves, M. M. V. Potential prebiotic properties of nuts and edible seeds and their relationship to obesity. Nutrients 10, 1645 (2018).

    PubMed Central  Article  CAS  Google Scholar 

  65. 65.

    Lamuel-Raventos, R. M. & Onge, M. P. S. Prebiotic nut compounds and human microbiota. Crit. Rev. Food Sci. Nutr. 57, 3154–3163 (2017).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  66. 66.

    Jiang, H. et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain. Behav. Immun. 48, 186–194 (2015).

    PubMed  Article  PubMed Central  Google Scholar 

  67. 67.

    Coello, K. et al. Gut microbiota composition in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives. Brain. Behav. Immun. 75, 112–118 (2019).

    PubMed  Article  PubMed Central  Google Scholar 

  68. 68.

    Gupta, A. et al. Association of Flavonifractor plautii, a flavonoid-degrading bacterium, with the gut microbiome of colorectal cancer patients in India. mSystems 4, 1–20 (2019).

    Article  Google Scholar 

  69. 69.

    Ghosh, T. S. et al. Mediterranean diet intervention alters the gut microbiome in older people reducing frailty and improving health status: The NU-AGE 1-year dietary intervention across five European countries. Gut 69, 1218–1228 (2020).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  70. 70.

    Meslier, V. et al. Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake. Gut 69, 1258–1268 (2020).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  71. 71.

    Nitisinprasert, S. et al. Microbial community of healthy Thai vegetarians and non-vegetarians, their core gut microbiota and pathogens risk. J. Microbiol. Biotechnol. 26, 1723–1735 (2016).

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  72. 72.

    Geerlings, S., Kostopoulos, I., de Vos, W. & Belzer, C. Akkermansia muciniphila in the human gastrointestinal tract: When, where, and how?. Microorganisms 6, 75 (2018).

    CAS  PubMed Central  Article  Google Scholar 

  73. 73.

    Do, M. H., Lee, E., Oh, M. J., Kim, Y. & Park, H. Y. High-glucose or-fructose diet cause changes of the gut microbiota and metabolic disorders in mice without body weight change. Nutrients 10, 761 (2018).

    PubMed Central  Article  CAS  Google Scholar 

  74. 74.

    Samuelson, D. R. et al. Alcohol consumption increases susceptibility to pneumococcal pneumonia in a humanized murine HIV model mediated by intestinal dysbiosis. Alcohol (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  75. 75.

    Manor, O. et al. Health and disease markers correlate with gut microbiome composition across thousands of people. Nat. Commun. 11, 1–12 (2020).

    ADS  Article  CAS  Google Scholar 

  76. 76.

    Dubinkina, V. B. et al. Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease. Microbiome 5, 141 (2017).

    PubMed  PubMed Central  Article  Google Scholar 

  77. 77.

    Valles-Colomer, M. et al. The neuroactive potential of the human gut microbiota in quality of life and depression. Nat. Microbiol. 4, 623–632 (2019).

    CAS  Article  Google Scholar 

  78. 78.

    Klindworth, A. et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucl. Acids Res. 41, 1–11 (2013).

    Article  CAS  Google Scholar 

  79. 79.

    Bolyen, E. et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat. Biotechnol. 37, 852–857 (2019).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  80. 80.

    Callahan, B. J. et al. DADA2: High-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581–583 (2016).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  81. 81.

    Bokulich, N. A. et al. Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2’s q2-feature-classifier plugin. Microbiome 6, 1–17 (2018).

    Article  Google Scholar 

  82. 82.

    Quast, C. et al. The SILVA ribosomal RNA gene database project: Improved data processing and web-based tools. Nucl. Acids Res. 41, 590–596 (2013).

    Article  CAS  Google Scholar 

  83. 83.

    McMurdie, P. J. & Holmes, S. Phyloseq: An R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE 8, e61217 (2013).

    ADS  CAS  PubMed  PubMed Central  Article  Google Scholar 

  84. 84.

    Hsieh, T. C., Ma, K. H. & Chao, A. iNEXT: An R package for rarefaction and extrapolation of species diversity (Hill numbers). Methods Ecol. Evol. 7, 1451–1456 (2016).

    Article  Google Scholar 

  85. 85.

    Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 1–21 (2014).

    Article  CAS  Google Scholar 

Download references


We would like to thank all the volunteers participating in the “Microbioma Español” Project. We are also very grateful to all the staff from ICLANP and Darwin Bioprospecting Excellence who were responsible of the sample shipment logistics. Finally, we would like to thank “Cátedra Extraordinaria Central Lechera Asturiana-UCM de formación e Investigacion en Nutrición y Educación para la salud” for their scientific advice.


This study was funded by Instituto Central Lechera Asturiana de Nutrición Personalizada (ICLANP). Instituto de Desarrollo Económico del Principado de Asturias (IDEPA) also funded this work through "PROGRAMA RIS3-EMPRESA" (reference IDE/2020/000363). AL-P is a recipient of a Doctorado Industrial fellowship from the Spanish Ministerio de Ciencia, Innovación y Universidades (reference DI-17-09613).

Author information




A.L.-P., J.P., M.P. & C.V. carried out and supervised all the experimental procedures, and performed all the analyses. M.H., J.R.I., L.C. and J.M. designed the study and helped with data interpretation and discussion. All the authors wrote and reviewed the article.

Corresponding authors

Correspondence to Adriel Latorre-Pérez or Marta Hernández.

Ethics declarations

Competing interests

MH and JRI are members of the ICLANP. The rest of the authors declare no conflict of interest.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Latorre-Pérez, A., Hernández, M., Iglesias, J.R. et al. The Spanish gut microbiome reveals links between microorganisms and Mediterranean diet. Sci Rep 11, 21602 (2021).

Download citation


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links